Hsing-Pang Hsieh

Director
​​National Health Research Institutes/Institute of Biotechnology and Pharmaceutical Research

Hsing-Pang Hsieh, Ph.D. 

Distinguished Investigator/Director, Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes

hphsieh@nhri.edu.tw
EDUCATION

Ph.D., Organic Chemistry, State University of New York (1993)
M.S., Organic Chemistry, National Tsing Hua University (1987)

B.S., Chemistry, National Tsing Hua University (1985)
PROFESSIONAL EXPERIENCES

Distinguished Investigator/Director, Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes. (2023/1~ ) 

Jointly Appointed Professor, Department of Chemistry, National Tsing Hua University. (2007 – present) 

Jointly Appointed Professor, Department of Chemistry, National Yang Ming Chiao Tung University. (2014 – present) 

Group Leader, Research Division, Central Epidemic Command Center for COVID-19. (2020/7 – 2023/4)  

Associate Director, Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes. (2015/4-2019/12) 

Director-General, Department of Research Planning and Development, National Health Research Institutes. (2012-2014) 

Director, Technology Transfer and Incubation Center, National Health Research Institutes. (2009-2012) 

Chief, Library, National Health Research Institutes. (2007-2009)
Dr. Hsing-Pang Hsieh’s lab specializes in drug discovery and developing on novel anticancer drugs “From Bench to Bedside”. I have published 148 scientific journals including 31 papers published in J. Med. Chem., top-one in the field of medicinal chemistry, and obtained 70 composition patents granted worldwide. More importantly, I invented three clinical candidates (A) DBPR112, was approved for IND by US FDA and TFDA on April 8 and August 23, 2016 and is undergoing Phase I clinical trial in Taiwan since July 2017; (B) DBPR114 was approved for IND by US FDA on July 20, 2017; (C) DBPR104, which was licensed to SynCore Bio, was completed Phase II clinical trial in Taiwan. Based on above achievements, Dr. Hsieh won for National Academy of Inventors, NAI Fellow (2023), two-time MOST Outstanding Research Award (2010 and 2017), Wang Ming-Ning Award (2016), TECO Award (2013), TienTe Lee Outstanding Award (2008).

Panel Discussion

.